Results 141 to 150 of about 409,422 (240)

INTRASCROTAL MALIGNANT MESOTHELIOMA

The Japanese Journal of Urology, 1988
T, Okutani, Y, Kobukata, M, Kodama, C, Masu, Y, Onishi, K, Inai   +5 more
openaire   +3 more sources

Anti-Ma1/Ma2 paraneoplastic neurological syndrome associated with malignant mesothelioma: a case study. [PDF]

BMJ Neurol Open
Mousapasandi A, Evans S, Kwon GT.
europepmc   +1 more source

Malignant peritoneal mesothelioma following asbestos exposure

, 1996
Clinical, epidemiological, and pathological studies have demonstrated that asbestosis plays a major role in the etiology of mesothelioma. The direct exposure of workers in industrialized countries to asbestos fibers and nonoccupational household contact ...
Özçelik, T., Kunt, E., Yolcu, I., Evrensel, T., Orhan, B., Manavoǧlu, O.   +5 more
core  

Establishment and Characterization of Canine Malignant Mesothelioma Cells. [PDF]

Yonago Acta Med
Osaki T, Kadohata T, Yasunaga M, Hishikawa S, Sunden Y, Takahashi K.   +5 more
europepmc   +1 more source

Cystic epithelioid malignant mesothelioma of the mesentery with rapid postoperative metastasis: an unusual case report. [PDF]

Front Med (Lausanne)
Xu T, Meng X, Gou X, Wang X, Luo S, Zhang D.   +5 more
europepmc   +1 more source

Malignant mesothelioma of the tunica vaginalis testis initially misdiagnosed as a benign testicular hydrocele: a case report. [PDF]

Front Oncol
Zhang C, Su H, Guo L, Li Z, Wang J, Chen J, Wang G.   +6 more
europepmc   +1 more source

Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort study. [PDF]

BMC Palliat Care
Mayland CR, Collinson M, Ahmedzai SH, Lucas J, Gath J, Darlison L, Defonseka D, Laird B, Stanley H, Danson S, Gardiner C, Bibby AC, ASSESS-meso collaborative.   +12 more
europepmc   +1 more source

Localised malignant mesothelioma presenting as an esophageal mass: An unusual manifestation. [PDF]

Radiol Case Rep
Yaxley KL, Rutland T, Jayawardena T, Law D, Weerakkody Y.   +4 more
europepmc   +1 more source

Radioimmunotherapy for Malignant Mesothelioma Targeting C-ERC/Mesothelin. [PDF]

Pharmaceuticals (Basel)
Hanaoka H, Yamaguchi A, Maeda M, Segawa T, Oriuchi N.   +4 more
europepmc   +1 more source

Malignant mesothelioma in the State of Qatar: A clinico-epidemiological study. [PDF]

Qatar Med J
Ibrahim WH, Fituri N, Abouzeid NH, Khasawneh SA, Elgara M, Hussein M, Bozom IA, Mohsen R, Ghazouani H.   +8 more
europepmc   +1 more source